Luyan Pharma Co Ltd (002788) — Strategic Asset Allocation Index
Luyan Pharma Co Ltd (002788) has a Strategic Asset Allocation Index of 53.9% as of September 2023. Strategic assets (PP&E of CN¥1.55 Billion plus long-term investments of CN¥-) total CN¥1.55 Billion, measured against net assets of CN¥2.88 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Luyan Pharma Co Ltd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Luyan Pharma Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Luyan Pharma Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of September 2023, the index stands at 53.9%, representing strategic assets of CN¥1.55 Billion against net assets of CN¥2.88 Billion CNY. For live market cap and overall valuation, see Luyan Pharma Co Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for Luyan Pharma Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Luyan Pharma Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Luyan Pharma Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 51.1% | CN¥1.43 Billion | CN¥1.43 Billion | CN¥- | CN¥2.79 Billion | ▲ +10.6 pp |
| 2021 | 40.5% | CN¥1.04 Billion | CN¥1.04 Billion | CN¥- | CN¥2.56 Billion | ▲ +5.4 pp |
| 2020 | 35.1% | CN¥845.53 Million | CN¥845.53 Million | CN¥- | CN¥2.41 Billion | ▼ -4.3 pp |
| 2019 | 39.4% | CN¥744.66 Million | CN¥744.66 Million | CN¥- | CN¥1.89 Billion | ▲ +1.7 pp |
| 2018 | 37.7% | CN¥623.68 Million | CN¥623.38 Million | CN¥300.00K | CN¥1.65 Billion | ▲ +2.2 pp |
| 2017 | 35.5% | CN¥555.62 Million | CN¥555.12 Million | CN¥500.00K | CN¥1.57 Billion | ▲ +6.3 pp |
| 2016 | 29.1% | CN¥401.72 Million | CN¥401.72 Million | CN¥- | CN¥1.38 Billion | ▼ -13.4 pp |
| 2015 | 42.6% | CN¥317.63 Million | CN¥317.63 Million | CN¥- | CN¥746.00 Million | ▼ -6.4 pp |
| 2014 | 48.9% | CN¥317.77 Million | CN¥317.77 Million | CN¥- | CN¥649.30 Million | ▼ -1.3 pp |
| 2013 | 50.2% | CN¥280.07 Million | CN¥280.07 Million | CN¥- | CN¥557.87 Million | ▲ +17.3 pp |
| 2012 | 32.9% | CN¥147.34 Million | CN¥147.34 Million | CN¥- | CN¥448.15 Million | ▲ +14.4 pp |
| 2011 | 18.5% | CN¥65.71 Million | CN¥65.71 Million | CN¥- | CN¥354.91 Million | — |